ResMed Inc. (FRA:RME)
Germany · Delayed Price · Currency is EUR 232.80
-8.20 (-3.40%)
Last updated: Aug 1, 2025
ResMed Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
| 5,146 | 4,685 | 4,223 | 3,578 | 3,197 | Upgrade | |
Revenue Growth (YoY) | 9.84% | 10.95% | 18.02% | 11.93% | 8.11% | Upgrade |
Cost of Revenue | 2,059 | 1,997 | 1,837 | 1,514 | 1,307 | Upgrade |
Gross Profit | 3,087 | 2,688 | 2,386 | 2,064 | 1,889 | Upgrade |
Selling, General & Admin | 991.02 | 917.14 | 874 | 737.51 | 670.39 | Upgrade |
Research & Development | 331.28 | 307.53 | 287.64 | 253.58 | 225.28 | Upgrade |
Operating Expenses | 1,400 | 1,304 | 1,234 | 1,062 | 971.88 | Upgrade |
Operating Income | 1,687 | 1,384 | 1,152 | 1,002 | 917.55 | Upgrade |
Interest Expense | - | -49.72 | -51.13 | -22.31 | -23.63 | Upgrade |
Interest & Investment Income | 4.11 | - | - | - | - | Upgrade |
Earnings From Equity Investments | 3.64 | -1.85 | -7.27 | -8.49 | -11.21 | Upgrade |
Currency Exchange Gain (Loss) | - | -0.14 | -0.45 | 2.81 | -0.75 | Upgrade |
Other Non Operating Income (Expenses) | -5.26 | 0.66 | -1.51 | 0.39 | 1.05 | Upgrade |
EBT Excluding Unusual Items | 1,690 | 1,333 | 1,092 | 974.55 | 883.02 | Upgrade |
Merger & Restructuring Charges | -2.03 | -64.23 | -20.13 | -1.86 | -13.87 | Upgrade |
Gain (Loss) on Sale of Investments | -10.3 | -4.05 | 9.92 | -12.2 | 14.52 | Upgrade |
Pretax Income | 1,678 | 1,265 | 1,102 | 960.48 | 883.66 | Upgrade |
Income Tax Expense | 276.84 | 243.85 | 204.11 | 181.05 | 409.16 | Upgrade |
Net Income | 1,401 | 1,021 | 897.56 | 779.44 | 474.51 | Upgrade |
Net Income to Common | 1,401 | 1,021 | 897.56 | 779.44 | 474.51 | Upgrade |
Net Income Growth | 37.20% | 13.75% | 15.15% | 64.26% | -23.67% | Upgrade |
Shares Outstanding (Basic) | 147 | 147 | 147 | 146 | 145 | Upgrade |
Shares Outstanding (Diluted) | 147 | 148 | 147 | 147 | 146 | Upgrade |
Shares Change (YoY) | -0.14% | 0.06% | 0.28% | 0.40% | 0.55% | Upgrade |
EPS (Basic) | 9.55 | 6.94 | 6.12 | 5.34 | 3.27 | Upgrade |
EPS (Diluted) | 9.51 | 6.92 | 6.09 | 5.30 | 3.24 | Upgrade |
EPS Growth | 37.43% | 13.63% | 14.91% | 63.58% | -24.12% | Upgrade |
Free Cash Flow | 1,662 | 1,302 | 573.63 | 216.31 | 634.01 | Upgrade |
Free Cash Flow Per Share | 11.28 | 8.82 | 3.89 | 1.47 | 4.33 | Upgrade |
Dividend Per Share | - | 1.920 | 1.760 | 1.680 | 1.590 | Upgrade |
Dividend Growth | - | 9.09% | 4.76% | 5.66% | 1.92% | Upgrade |
Gross Margin | 59.99% | 57.38% | 56.50% | 57.68% | 59.10% | Upgrade |
Operating Margin | 32.79% | 29.54% | 27.28% | 28.01% | 28.70% | Upgrade |
Profit Margin | 27.22% | 21.79% | 21.25% | 21.78% | 14.84% | Upgrade |
Free Cash Flow Margin | 32.29% | 27.79% | 13.58% | 6.04% | 19.83% | Upgrade |
EBITDA | 1,886 | 1,534 | 1,292 | 1,126 | 1,029 | Upgrade |
EBITDA Margin | 36.65% | 32.73% | 30.60% | 31.47% | 32.19% | Upgrade |
D&A For EBITDA | 198.47 | 149.42 | 140.1 | 124.06 | 111.43 | Upgrade |
EBIT | 1,687 | 1,384 | 1,152 | 1,002 | 917.55 | Upgrade |
EBIT Margin | 32.79% | 29.54% | 27.28% | 28.01% | 28.70% | Upgrade |
Effective Tax Rate | 16.50% | 19.28% | 18.53% | 18.85% | 46.30% | Upgrade |
Revenue as Reported | - | 4,685 | 4,223 | 3,578 | 3,197 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.